TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 133 filers reported holding TRANSLATE BIO INC in Q2 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $14,454,000 | +59.9% | 524,805 | -4.2% | 0.01% | +66.7% |
| Q1 2021 | $9,038,000 | -6.3% | 548,084 | +4.8% | 0.00% | -25.0% |
| Q4 2020 | $9,644,000 | +56.0% | 523,230 | +15.2% | 0.00% | +33.3% |
| Q3 2020 | $6,184,000 | +169.1% | 454,318 | +254.3% | 0.00% | +200.0% |
| Q2 2020 | $2,298,000 | +151.7% | 128,234 | +40.1% | 0.00% | 0.0% |
| Q1 2020 | $913,000 | +30.1% | 91,501 | +6.2% | 0.00% | – |
| Q4 2019 | $702,000 | -4.7% | 86,176 | +15.9% | 0.00% | – |
| Q3 2019 | $737,000 | -21.5% | 74,330 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $939,000 | +40.8% | 74,330 | +13.6% | 0.00% | – |
| Q1 2019 | $667,000 | +376.4% | 65,438 | +252.0% | 0.00% | – |
| Q4 2018 | $140,000 | -24.7% | 18,590 | 0.0% | 0.00% | – |
| Q3 2018 | $186,000 | – | 18,590 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 2,656,517 | $48,960,000 | 10.98% |
| Copernicus Capital Management, LLC | 12,091 | $223,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $40,229,000 | 3.10% |
| Baupost Group | 18,044,239 | $326,236,000 | 3.01% |
| DAFNA Capital Management LLC | 225,393 | $4,154,000 | 1.24% |
| RTW INVESTMENTS, LP | 2,978,427 | $54,892,000 | 0.92% |
| MARATHON CAPITAL MANAGEMENT | 143,275 | $2,640,000 | 0.78% |
| Bain Capital Public Equity Management II, LLC | 627,387 | $11,563,000 | 0.59% |
| Artal Group S.A. | 1,200,000 | $22,116,000 | 0.48% |
| Birchview Capital, LP | 30,000 | $553,000 | 0.32% |